Nile Therapeutics, Inc (NLTX) Posts Q1 Loss of $0.07, Misses Views
Nile Therapeutics, Inc (Nasdaq: NLTX) reports Q1 loss of $0.07, versus the analyst estimate of ($0.06).
Get Alerted When News Hits On This Stock - FREE!
Nile Therapeutics, Inc (Nasdaq: NLTX) reports Q1 loss of $0.07, versus the analyst estimate of ($0.06).